X-14845014-A-G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001018113.3(FANCB):​c.1769T>C​(p.Phe590Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0015 in 1,208,655 control chromosomes in the GnomAD database, including 5 homozygotes. There are 649 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0011 ( 0 hom., 40 hem., cov: 23)
Exomes 𝑓: 0.0015 ( 5 hom. 609 hem. )

Consequence

FANCB
NM_001018113.3 missense

Scores

5
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:12

Conservation

PhyloP100: 5.04

Publications

3 publications found
Variant links:
Genes affected
FANCB (HGNC:3583): (FA complementation group B) This gene encodes a member of the Fanconi anemia complementation group B. This protein is assembled into a nucleoprotein complex that is involved in the repair of DNA lesions. Mutations in this gene can cause chromosome instability and VACTERL syndrome with hydrocephalus. [provided by RefSeq, Apr 2016]
FANCB Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group B
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • VACTERL association, X-linked, with or without hydrocephalus
    Inheritance: XL Classification: STRONG Submitted by: Genomics England PanelApp
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • VACTERL with hydrocephalus
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004327774).
BP6
Variant X-14845014-A-G is Benign according to our data. Variant chrX-14845014-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 246611.We mark this variant Benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS2
High Hemizygotes in GnomAd4 at 40 AR,XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FANCBNM_001018113.3 linkc.1769T>C p.Phe590Ser missense_variant Exon 8 of 10 ENST00000650831.1 NP_001018123.1 Q8NB91A0A024RBW1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FANCBENST00000650831.1 linkc.1769T>C p.Phe590Ser missense_variant Exon 8 of 10 NM_001018113.3 ENSP00000498215.1 Q8NB91

Frequencies

GnomAD3 genomes
AF:
0.00111
AC:
124
AN:
112170
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000972
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000472
Gnomad ASJ
AF:
0.0144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00146
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00418
Gnomad NFE
AF:
0.00135
Gnomad OTH
AF:
0.000665
GnomAD2 exomes
AF:
0.00158
AC:
289
AN:
182657
AF XY:
0.00183
show subpopulations
Gnomad AFR exome
AF:
0.000228
Gnomad AMR exome
AF:
0.000439
Gnomad ASJ exome
AF:
0.0147
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00125
Gnomad OTH exome
AF:
0.00289
GnomAD4 exome
AF:
0.00154
AC:
1684
AN:
1096433
Hom.:
5
Cov.:
30
AF XY:
0.00168
AC XY:
609
AN XY:
361935
show subpopulations
African (AFR)
AF:
0.000190
AC:
5
AN:
26357
American (AMR)
AF:
0.000313
AC:
11
AN:
35172
Ashkenazi Jewish (ASJ)
AF:
0.0129
AC:
250
AN:
19332
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30185
South Asian (SAS)
AF:
0.00248
AC:
134
AN:
54041
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40511
Middle Eastern (MID)
AF:
0.00339
AC:
14
AN:
4128
European-Non Finnish (NFE)
AF:
0.00140
AC:
1175
AN:
840677
Other (OTH)
AF:
0.00206
AC:
95
AN:
46030
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
59
117
176
234
293
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00110
AC:
124
AN:
112222
Hom.:
0
Cov.:
23
AF XY:
0.00116
AC XY:
40
AN XY:
34408
show subpopulations
African (AFR)
AF:
0.0000970
AC:
3
AN:
30942
American (AMR)
AF:
0.000472
AC:
5
AN:
10601
Ashkenazi Jewish (ASJ)
AF:
0.0144
AC:
38
AN:
2648
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3574
South Asian (SAS)
AF:
0.00146
AC:
4
AN:
2733
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6073
Middle Eastern (MID)
AF:
0.00459
AC:
1
AN:
218
European-Non Finnish (NFE)
AF:
0.00135
AC:
72
AN:
53229
Other (OTH)
AF:
0.000657
AC:
1
AN:
1522
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00202
Hom.:
101
Bravo
AF:
0.00109
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00104
AC:
3
ESP6500AA
AF:
0.000261
AC:
1
ESP6500EA
AF:
0.00163
AC:
11
ExAC
AF:
0.00129
AC:
157
EpiCase
AF:
0.00191
EpiControl
AF:
0.00160

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:12
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
May 29, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 12, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not specified Benign:2
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 12, 2021
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fanconi anemia complementation group B Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

History of neurodevelopmental disorder Uncertain:1
Oct 03, 2012
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Co-segregation data for this variant is currently unavailable.This variant has not been detected in conjunction with a pathogenic mutation to date.Based on data from the NHLBI Exome Sequencing Project (ESP), the C-allele was absent in 1997 male alleles studied and was not observed in the homozygous state in 3382 female alleles studied (http://browser.1000genomes.org Released July 2010). This amino acid position is not conserved on limited sequence alignment.This alteration is predicted to be possibly damaging with a score of 0.605 (sensitivity: 0.80; specificity: 0.82)This alteration is predicted to be tolerated with a score of 0.140 (conservation: 2.54) -

Fanconi anemia Benign:1
Dec 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

FANCB-related disorder Benign:1
Apr 19, 2021
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Fanconi anemia complementation group A Benign:1
May 28, 2019
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

VACTERL association, X-linked, with or without hydrocephalus Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Malignant tumor of breast Benign:1
-
Center of Medical Genetics and Primary Health Care
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
17
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.47
T;T;T
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.51
T;.;T
M_CAP
Benign
0.0083
T
MetaRNN
Benign
0.0043
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.6
L;L;.
PhyloP100
5.0
PrimateAI
Benign
0.45
T
PROVEAN
Uncertain
-3.4
D;D;D
REVEL
Benign
0.21
Sift
Benign
0.052
T;T;T
Sift4G
Uncertain
0.0030
D;D;D
Polyphen
0.18
B;B;.
Vest4
0.20
MVP
0.57
MPC
0.25
ClinPred
0.028
T
GERP RS
4.3
Varity_R
0.29
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142959373; hg19: chrX-14863136; API